Skimpy Coverage of Alpha Clinic Concept Approval

Posted: August 1, 2013 at 3:13 pm

News coverage of approval of the
California stem cell agency's ambitious, $70 million Alpha clinic
plan has been quite light but does include one article in the Los
Angeles Times, the state's largest circulation newspaper.
The concept proposal was ratified last
week by the agency's board with RFAs scheduled to be posted in
October. The agency is seeking to build a basis for a robust stem
cell clinic business in California that would have an international
reach and give the state dominance in the industry.
Karen Kaplan's story in the Times last
week quoted CIRM President Alan Trounson as saying in 2010 about
agency's goals.

“If we went 10 years and had no
clinical treatments, it would be a failure. We need to demonstrate
that we are starting a whole new medical revolution.”

The stem cell agency was created by
voters in 2004 and funded with $3 billion in borrowed money. It will
run out of funds for new grants in 2017.
Outsourcing-Pharma.com caught up with
the plan this week in a story that said,

“The opportunity to run trails under
the well-funded CIRM could be a boon for CROs (contract research
organizations)....But the difficulties of handling the stem cells and
gathering enough patients to enroll in a trial may prove daunting for whatever
company tries to conduct the trials.”

The article also quoted CIRM spokesman
Kevin McCormack as saying,

 “No one has reached out to us yet
because the specific details of what we are looking for in the
clinics have not yet been decided.”

That said, considerable information is
available here, here, here, here and here.)
Also reporting on board approval of the
Alpha clinic plan was GenNews.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/g-INer3wY50/skimpy-coverage-of-alpha-clinic-concept.html

Related Posts